Profusa signs LOI to buy PanOmics assets for $30M equity; issues $555k convertible note

Profusa, Inc.

Non-binding LOI to acquire Bio Insights' PanOmics assay for $30M in stock (460k common + 59.54M conversion shares) plus 3% annual net revenue royalty.
Issued $555,556 senior secured convertible note to Ascent (12% interest, due 2027, convertible at $0.50) and warrant for 1.11M shares at $0.50.
Amendment No. 4 allows up to $12.2M additional notes with at least 10% OID; $1.67M principal release condition.
Acquisition requires shareholder vote by June 30, 2026 and $10M equity financing within 30 days post-closing.
Bio Insights gets one board nominee; management retention shares (12% fully diluted) for CEO/CFO.

item 1.01 item 2.03 item 3.02 item 8.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001213900-26-040111
form_type: 8-K
ticker: PFSA
cik: 0001859807
company_name: Profusa, Inc.
filed_at: 2026-04-06T23:59:59+00:00
discovered_at: 2026-05-14T18:02:33.162872+00:00
generated_at: 2026-05-15T07:25:53.234906+00:00
sec_items: ["1.01", "2.03", "3.02", "8.01", "9.01"]
event_type: m_and_a
sentiment: neutral
materiality_score: 0.8
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001213900-26-040111
json_url: https://secwatch.observer/filing/0001213900-26-040111.json
markdown_url: https://secwatch.observer/filing/0001213900-26-040111.md
text_url: https://secwatch.observer/filing/0001213900-26-040111.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1859807/000121390026040111/0001213900-26-040111-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1859807/000121390026040111/ea0285151-8k_profusa.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001213900-26-040111

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.